首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Cancer Research And Therapeutics

Journal Of Cancer Research And Therapeutics杂志,由Wolters Kluwer Medknow Publications出版,于2005年创刊,Quarterly,出版语言English,ISSN:0973-1482,E-ISSN:0974-1127。

投稿咨询
Journal Of Cancer Research And Therapeutics
Journal Of Cancer Research And Therapeutics
Journal Of Cancer Research And Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q4
中科院分区
4区
影响因子
1.4
CiteScore
2.3
期刊收录
SCI、SCIE

Journal Of Cancer Research And Therapeutics(中文译名:《癌症研究与治疗学杂志》),ISSN:0973-1482,EISSN:0974-1127,是Wolters Kluwer Medknow Publications出版的国际性学术期刊,创刊于2005年,以Quarterly形式稳定发行,2026年总发文量约222篇。该刊采用OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达1.4,2025年期刊CiteScore为2.3,2025年期刊自引率约14.3%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Cancer Research And Therapeutics长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约6月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDIndia、Turkey、Iran、USA、Japan、Italy等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 287 / 333

14

学科:ONCOLOGY SCIE Q4 291 / 333

12.76

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 275 / 328

16.3

学科:ONCOLOGY SCIE Q4 282 / 328

14.18


中国学者近期发文

1
An analysis of the clinical efficacy and safety of a temperature-sensitive liquid embolic agent loaded with lobaplatin for the treatment of unresectable primary hepatocellular carcinoma through chemoembolizatio

Author:Zhou, Shengyu; Lin, Qingfeng; Zhong, Junsheng; Chen, Jian

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 504-508. DOI: 10.4103/jcrt.jcrt_2250_24

2
Supine/prone position fixation treatment in cervical cancer radiotherap

Author:Zheng, Zhiman; Liu, Dongyue; Su, Yangmei

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 401-408. DOI: 10.4103/jcrt.jcrt_2050_24

3
MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatmen

Author:Zhao, Chang; Qin, Guchun; Ling, Caixia; Zhao, Yang; Huang, Yunxi; Jiang, Zelong; Zhou, Niqiang; Liu, Junjie; Su, Danke; Jiang, Jinghang

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1531_24

4
Deep learning model for predicting the RAS oncogene status in colorectal cancer liver metastase

Author:Zhang, Baogen; Wang, Kai; Xu, Ting; Zhu, Haibin; Wang, Kangjie; Wang, Jing; Xiang, Yaoxian; He, Xuelei; Zhu, Siyu; An, Chao; Yan, Dong

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1910_24

5
Advancing colorectal cancer diagnosis: The role of tumor-derived serum galanin and haptoglobin as novel biomarker

Author:Yuan, Ning; Ren, Ren; Li, Dan; Liang, Xinmei; Pang, Xiaochen; Wang, Jun; Feng, Xiaodong; Zhang, Zhijun

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 417-424. DOI: 10.4103/jcrt.jcrt_1742_24

6
Impact of materia medica in combination with transarterial chemoembolization on inflammatory markers in patients with hepatocellular carcinoma: A systematic review and meta-analysi

Author:Yu, Chengyang; Yu, Yifan; Wang, Xiongwen

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. -. DOI: 10.4103/jcrt.jcrt_1954_24

7
A study on the safety and efficacy of a robotic-assisted navigation and positioning system in CT-guided percutaneous biopsy of thoracic and abdominal tumor

Author:You, Xiang; Zhu, Xiaoli; Chen, Qingjie; Chen, Jin; Lin, Huihuang; Huang, Bingyu; Yang, Dongyong; Hu, Hongjie; Lin, Zhengyu

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 389-394. DOI: 10.4103/jcrt.jcrt_1888_24

8
Oral and intestinal flora translocation and tumor developmen

Author:Ye, Zhiyuan; Gao, Linglin; Guo, Zhi; Wang, Qiang

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 323-333. DOI: 10.4103/jcrt.jcrt_50_24

9
Immediate changes in MRI signals after the MRI-guided microwave ablation of malignant liver tumor

Author:Yang, Jian; Song, Yunying; Geng, Jiwei; Zhao, Jikun; Xiao, Bin; Zhao, Hua; Lin, Zhengyu; Zhao, Derong

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 435-441. DOI: 10.4103/jcrt.jcrt_1458_24

10
Proteomics analysis explored the changes in the tumor microenvironment of CT26 tumor-bearing mice after microwave ablatio

Author:Xue, Huiwen; Li, Zhen; Yu, Lu; Lu, Qianqian; Niu, Siyi; Liang, Jing; Wei, Zhigang; Ye, Xin; Xie, Qi

Journal: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. 2025; Vol. 21, Issue 2, pp. 494-503. DOI: 10.4103/jcrt.jcrt_2113_24


在线咨询

Journal Of Cancer Research And Therapeutics

国际简称:J CANCER RES THER参考译名:癌症研究与治疗学杂志

年发文量:222 CiteScore:2.3 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:91.44%

杂志社联系方式:MEDKNOW PUBLICATIONS, A-108-109 KANARA BUSINESS CENTRE, GHAKTOPAR, MUMBAI, INDIA, 400075

Journal Of Cancer Research And Therapeutics